頁籤選單縮合
題 名 | 某區域教學醫院腫瘤科病房降低中心導管相關血流感染之經驗=The Reduction of Central Line-Associated Bloodstream Infections in Oncology Wards in a Regional Teaching Hospital |
---|---|
作 者 | 李怡頡; 林欣樺; 莊依如; 官惠貞; 紀嘉君; 林宜君; 董紹賢; 吳美珠; 何秀燕; 吳淑貞; 李吟玲; 盧進德; | 書刊名 | 感染控制雜誌 |
卷 期 | 26:1 2016.02[民105.02] |
頁 次 | 頁1-12 |
分類號 | 419.38 |
關鍵詞 | 血流感染; 中心導管; 組合式照護; Bloodstream infection; Central line; Care bundle; |
語 文 | 中文(Chinese) |
中文摘要 | 腫瘤病人需要中心導管注射化學治療藥物和營養輸液,病人本身就是導管相關血流感染的高風險族群。為了降低腫瘤科病房中心導管相關血流感染密度, 於2011至2014年導入『中心導管相關血流感染之感染管制措施』,內容包括: 一、植入式輸液導管(Port-A導管)之護理人員認證制度。二、Port-A導管角針置放之查檢表。三、擴大皮膚消毒範圍。四、擴大無菌面及穿著無菌隔離衣。五、以2% chlorhexidine進行皮膚消毒。六、加入『中心導管照護品質改善計畫』。腫瘤科病房中心導管相關血流感染密度由介入期前2010年3.34‰,下降至介入期結束2014年1.05‰(p<0.001),中心導管相關血流感染的細菌種類及表皮菌種,如凝固酶陰性葡萄球菌的數目(9株至1株)及百分比(13.8%至4.0%,p=0.183)也呈現逐年下降的趨勢。總而言之,利用中心導管相關血流感染之各項感染管制措施, 能有效降低腫瘤科住院病房中心導管相關血流感染密度。 |
英文摘要 | Cancer patients always need a central line for infusion of chemotherapy and nutritional fluid supplements. They are at high risk for central line-associated bloodstream infection (CLABSI). In order to reduce the incidence of CLABSI on the oncology ward, we implemented combined measures for infection control from 2011 to 2014. Care bundles included: (1) verification and instructions for Port-A-Cath needle insertion, (2) a Port-A-Cath identification check list, (3) instructions on hand hygiene, (4) maximization of sterile barrier precautions, (5) use of 2% chlorhexidine for sterilization, and (6) joint responsibility for central line care bundles. After implementation of central line care bundles, CLABSI incidence declined from 3.34 in 2010 to 1.05 in 2014(P < 0.001),Among CLABSI isolates, the number and percentage of coagulase-negative staphylococci declined from 9 to 1 and 13.8% to 4.0% (P = 0.183), respectively. Thus, implementation of combined measures for infection control can reduce CLABSI incidence in the oncology ward. |
本系統中英文摘要資訊取自各篇刊載內容。